Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX�
Read time: 1 mins
Last updated:2nd Jul 2014
This study will use retrospective data to evaluate the safety and efficacy of OZURDEX® (dexamethasone intravitreal implant 0.7 mg) in the treatment of macular oedema due to retinal vein occlusion (RVO) in clinical practice. No intervention will be administered as part of this study.
|Study start date||2014-07-02|